Abstract
The assessment of health outcomes is rapidly evolving, with a growing interest in outcomes reported by the patient. Patient-reported outcomes (PROs) constitute any report of the status of a patient’s health condition that comes directly from the patient without any interpretation of the patient’s response by a clinician or anyone else (US Food and Drug Administration 2009). Examples include patient’s report of their symptoms, physical function or patient satisfaction. However, emphasis on the patient’s own self-report has increased in the last two decades.
Living with a Chronic Disease
(Anecdote)
Having a chronic illness, Molly thought, was like being invaded. Her grandmother back in Michigan used to tell about the day one of their cows got loose and wandered into the parlor, and the awful time they had getting her out. That was exactly what Molly’s arthritis was like: as if some big old cow had got into her house and wouldn't go away. It just sat there, taking up space in her life and making everything more difficult, mooing loudly from time to time and making cow pies, and all she could do really was edge around it and put up with it.
When other people first became aware of the cow, they expressed concern and anxiety. They suggested strategies for getting the animal out of Molly's parlor: remedies and doctors and procedures, some mainstream and some New Age. They related anecdotes of friends who had removed their own cows in one way or another. But after a while they had exhausted their suggestions. Then they usually began to pretend that the cow wasn't there, and they preferred for Molly to go along with the pretense.
Alison Lurie, The Last Resort
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Basch E (2013) Toward patient-centered drug development in oncology. N Engl J Med 369(5):397–400
Basra MKA, Shahrukh M (2009) Burden of skin diseases. Expert Rev Pharmacoecon Outcomes Res 9(3):271–283
Bertsias G et al (2008) EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 67(2):195–205
Black N (2013) Patient reported outcome measures could help transform healthcare. BMJ 346:f167
Bottomley A et al (2009) Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. Eur J Cancer 45(3):347–353
Coons SJ et al (2011) The patient-reported outcome (PRO) consortium: filling measurement gaps for PRO end points to support labeling claims. Clin Pharmacol Ther 90(5):743–748
Department of Health (2014) Title: the NHS outcomes framework 2015/16. Department of Health, London, pp 1–22
Devlin NJ, Appleby J (2010) Getting the most out of PROMS. The Kings Fund, Office of Health Economics, London
Doward LC et al (2010) Patient reported outcomes: looking beyond the label claim. Health Qual Life Outcomes 8:89
Gladman DD et al (2003) Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol 30(9):1955–1959
Gnanasakthy A et al (2013) Potential of patient-reported outcomes as nonprimary endpoints in clinical trials. Health Qual Life Outcomes 11(1):83
Gnanasakthy A et al (2016) Patient-reported outcomes labeling for products approved by the office of hematology and oncology products of the US Food and Drug Administration (2010–2014). J Clin Oncol 34(16):1928–1934
Greenhalgh J (2009) The applications of PROs in clinical practice: what are they, do they work, and why? Qual Life Res 18(1):115–123
Grob JJ (2007) Why are quality of life instruments not recognized as reference measures in therapeutic trials of chronic skin disorders? J Investig Dermatol 127(10):2299–2301
Hermansen SE et al (2002) Patients’ and doctors’ assessment of skin disease handicap. Clin Exp Dermatol 27(3):249–250
Jemec GB, Wulf HC (1996) Patient-physician consensus on quality of life in dermatology. Clin Exp Dermatol 21(3):177–179
Kluetz PG et al (2016) Focusing on core patient-reported outcomes in cancer clinical trials: symptomatic adverse events, physical function, and disease-related symptoms. Clin Cancer Res 22(7):1553–1558
Lisnevskaia L et al (2014) Systemic lupus erythematosus. Lancet 384(9957):1878–1888
Lohr KN, Zebrack BJ (2009) Using patient-reported outcomes in clinical practice: challenges and opportunities. Qual Life Res 18(1):99–107
Luckett T et al (2009) Improving patient outcomes through the routine use of patient-reported data in cancer clinics: future directions. Psychooncology 18(11):1129–1138
McKenna SP (2011) Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science. BMC Med 9(1):86
Nijsten T (2012) Dermatology Life Quality Index: time to move forward. J Investig Dermatol 132(1):11–13
Padilla GV et al (1996) Quality of life - cancer. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Lippincott-Raven, Philadelphia, pp 301–308
Reeve BB et al (2014) Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst 106(7):pii: dju129
Renzi C et al (2001) Factors associated with patient satisfaction with care among dermatological outpatients. Br J Dermatol 145(4):617–623
Robinson D, Aguilar D (2010) Impact of systemic lupus erythematosus on health, family, and work: the patient perspective. Arthritis care Res 62(2):266–273
Salek M (1998) Compendium of quality of life instruments. Euromed Communications, Haslemere
Salek MS, Luscombe DK (1992) Health-related quality of life assessment: a review. J Drug Dev 5(3):137–153
Schmitt J, Ford DE (2007) Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis – a structural equations modeling approach. Gen Hosp Psychiatry 29(2):134–140
Sutanto B et al (2013) Experiences and perspectives of adults living with systemic lupus erythematosus: thematic synthesis of qualitative studies. Arthritis Care Res 65(11):1752–1765
US Food and Drug Administration (2009) Guidance for Industry: Patient-reported outcome measures: use in medicinal product development to support labeling claims. Health Qual Life Outcomes 4:79
World Health Organisation (2014) Global health estimates 2014 summary tables: DALY by cause, age and sex, by WHO Regio, 2000–2012. World Health Organisation, Geneva
Wörle B et al (2007) Definition and treatment of primary hyperhidrosis. J German Soc Dermatol 5(7):625–628
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kamudoni, P., Johns, N., Salek, S. (2018). Overview. In: Living with Chronic Disease: Measuring Important Patient-Reported Outcomes. Adis, Singapore. https://doi.org/10.1007/978-981-10-8414-0_1
Download citation
DOI: https://doi.org/10.1007/978-981-10-8414-0_1
Published:
Publisher Name: Adis, Singapore
Print ISBN: 978-981-10-8413-3
Online ISBN: 978-981-10-8414-0
eBook Packages: MedicineMedicine (R0)